Skip to content
Sunday, November 15, 2026
Prime VIP Studio offers expert web design, development, and…

Zimbabwe Declines ‘Lopsided’ US Health Aid Deal Because of Information Fears

Health aid illustration
The offered US financial assistance would have supported initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a major US healthcare agreement valued at $367m (£272m) over five years over Washington's insistence on confidential biological samples.

The decision came to light after a government memo dated December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "skewed".

An official spokesperson later explained that the US was demanding access to biological samples for scientific study and profit but refused to share the benefits from future treatments.

"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged continued talks to reach a deal agreeable to both sides so the country's critical HIV treatment initiative can be sustained.

Broader Context

This rejection follows a comparable situation in neighbouring Kenya, where a court blocked a similar deal with the US following concerns were raised about the security of citizens' medical information.

Since resuming office recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.

According to statements, 16 nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment through US-supported initiatives," Tremont commented.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its biological resources and data indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," he stated.

"Effectively, our country would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our people if a future disease outbreak arise."

National Interest and Global Health

Mangwana further said that the US's withdrawal from the global health body and its push of bilateral deals were disrupting structures already established through the global health agency.

The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.

"This mechanism is intended to ensure that when a nation provides its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.

"We welcome continued dialogue with our US partners on how future collaboration might be arranged in a way that honours the sovereignty and dignity of each country."

Medical Community Reaction

Medical experts said it recognised the government's concerns, but recommended that talks need to persist considering much of the country's HIV programmes were funded by international support.

"If technical issues exist, including those relating to information security or agreement terms, these can frequently be resolved through technical clarification and mutually agreed protections," it said.

The situation underscores the ongoing challenges between accepting much-needed international aid and protecting a country's data in an ever more data-driven world.

The writer

Jeffrey Brooks

A digital strategist with over a decade of experience in web development and SEO, specializing in creating impactful online presences for diverse industries.

Prime VIP Studio

Type to search articles.